CAS 2669009-92-9

Formel: C23H27FN4O6S

InChl: InChI=1S/C23H27FN4O6S/c1-25-35(31,32)26-19-8-6-7-14(21(19)24)11-17-18(13-27(2)3)16-10-9-15(33-23(30)28(4)5)12-20(16)34-22(17)29/h6-10,12,25-26H,11,13H2,1-5H3

InChI Key: VGDONWMTHHBKMZ-UHFFFAOYSA-N

SMILES: CNS(=O)(=O)NC1=CC=CC(=C1F)CC2=C(C3=C(C=C(C=C3)OC(=O)N(C)C)OC2=O)CN(C)C

Atebimetinib

CAS: 2669009-92-9

Atebimetinib

Formel: C₂₃H₂₇FN₄O₆S

Reinheit: 99%

Molekulargewicht: 506.55

Ref: 54-BUP23757

4-((Dimethylamino)methyl)-3-(2-fluoro-3-((N-methylsulfamoyl)amino)benzyl)-2-oxo-2H-chromen-7-yl dimethylcarbamate

CAS: 2669009-92-9

Formel: C₂₃H₂₇FN₄O₆S

Reinheit: 98%

Farbe und Form: Solid

Molekulargewicht: 506.5471

Ref: IN-DA0F5854

Atebimetinib

CAS: 2669009-92-9

4-((Dimethylamino)methyl)-3-(2-fluoro-3-((N-methylsulfamoyl)amino)benzyl)-2-oxo-2H-chromen-7-yl dimethylcarbamate

Reinheit: 95%

Ref: IN-DG02791469

Atebimetinib

CAS: 2669009-92-9

Atebimetinib, Oral MEK inhibitor, suppresses MAPK signaling, for combination therapy in metastatic pancreatic cancer and NSCLC.

Formel: C₂₃H₂₇FN₄O₆S

Reinheit: 99.40%

Farbe und Form: White Solid

Molekulargewicht: 506.55

Ref: TM-T206215